The quarterly just released suggested IMU didn't need to do a CR right now until the expected clinical trial updates are released but they would have needed additional fund in the 2nd half of 2025, with the additional $20M and $26M warrant exercisable at 5c then they don't need any funds for 2025 especially with around $20M R&D rebate outstanding for last financial year.
IMU Price at posting:
3.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)